Details

NameSymbolSector
BIOFIL CHEMICALS & PHARMACEUTICALS LIMITEDBIOFILCHEMPharmaceuticals
Open
41.5
High
42.4
Low
40.3
Close
41.35
Volume
15736
Exchange
nse
Time
03-Oct-2025

Outlook

Score:

3

Rating:

RISKY

Candlestick Pattern

CandlepatternofBiofilChemicals&Pharmaceuticalsis
Spinning Top
EstimatedStoplossofBiofilChemicals&Pharmaceuticalsis
42.4
BiofilChemicals&Pharmaceuticalshasa
Bearishℹ
pattern.
Formationof
Spinning Top
candlepatternindicatesthetrenddirectionofBiofilChemicals&Pharmaceuticalsis
Unpredictableℹ
.

Trend

BiofilChemicals&Pharmaceuticalsisin
Sideways trendℹ
.
PriceofBiofilChemicals&Pharmaceuticalsis
Downℹ
by

4.44

%.
Target
Buy@

41.02

Sell@

46.94

Current@

41.35

Volume

ThetradesofBiofilChemicals&Pharmaceuticalshavebeenin
Immenseℹ
volume.
ThevolumetradesforBiofilChemicals&Pharmaceuticalsare
Bearishℹ
with
Strong Sellersℹ
ThetradevolumeofBiofilChemicals&Pharmaceuticalsis

Up

by

63.62

%

Valuation

ThecurrentmarketpriceofBiofilChemicals&Pharmaceuticalsis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth50crandtotalassetsworth50cr,thebalancesheetofBiofilChemicals&Pharmaceuticalsis:
Balancedℹ
.
Cashflow
BiofilChemicals&Pharmaceuticalshas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 2cr

.Itis
Downℹ
by

200

%.
100% i.e. ₹ 1cr spent in operatingℹ
0% in investingℹ
0% in financingℹ
0% in otherℹ
BiofilChemicals&Pharmaceuticalshas
Sufficientℹ
cashflowbecausethereis

Surplus

of

₹ 2cr

.Itis
Upℹ
by

0

%.
100% i.e. ₹ 2cr earned in operatingℹ
0% in investingℹ
0% in financingℹ
0% in otherℹ
Income
TheincomeofBiofilChemicals&Pharmaceuticalsis

₹ 9cr

and

Profit

is:

₹ 2cr

BiofilChemicals&PharmaceuticalsProfitisupby:

200

%andIncomeisUpby:

12.5

%
TheincomeofBiofilChemicals&Pharmaceuticalsis

₹ 8cr

and

Loss

is:

₹ 0cr

BiofilChemicals&PharmaceuticalsLossesincreasedby:

0

%andIncomeisDownby:

42.86

%
TheincomeofBiofilChemicals&Pharmaceuticalsis

₹ 14cr

and

Loss

is:

₹ 0cr

BiofilChemicals&PharmaceuticalsLossesincreasedby:

0

%andIncomeisUpby:

600

%
By using this site you agree to the use of cookies to deliver a better site experience.